ASSET PURCHASE AGREEMENT among LEO PHARMA A/S, and LEO SPINY MERGER SUB, INC., as Buyers and TIMBER PHARMACEUTICALS, INC., TIMBER PHARMACEUTICALS, LLC, and BIOPHARMX, INC. as Sellers dated as of November 17, 2023Asset Purchase Agreement • November 17th, 2023 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”), dated as of November 17, 2023, is entered into among Timber Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, Timber Pharmaceuticals, LLC (“Timber LLC”), a Delaware limited liability company, BioPharmX, Inc. (“BioPharmX”), a Nevada corporation], together with the Company, Timber LLC and BioPharmX, the “Sellers”, and each being a “Seller”), and LEO Pharma A/S, a Danish Aktieselskab (“LEO Pharma”) and LEO Spiny Merger Sub, Inc. (“LEO Spiny” and together with LEO Pharma, “Buyers”), a Delaware corporation.
Date] [Name] [Address] Dear ________________:Retention Bonus Agreement • November 17th, 2023 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Retention Bonus Agreement the (“Agreement”) is entered into as of the date written below between [_______] (“you”) and Timber Pharmaceutical, Inc. (the “Company”) for the purpose of setting forth the requirements for you to receive additional compensation as consideration for your continued employment with and efforts on behalf of the Company as the Company continues to pursue all efforts to complete and consummate a Transaction (as defined below).
